
InsightRX
@insightrx
InsightRX provides software that helps clinicians optimize dosing regimens, reach clinical targets faster, reduce adverse events, and improve patient outcomes.
ID: 3192366386
http://insight-rx.com 11-05-2015 16:48:13
841 Tweet
586 Takipçi
624 Takip Edilen


This recent study investigated which factors are associated with receiving pharmacogenetically targeted drugs & estimated cost-effects of untargeted pre-emptive #pharmacogenetic panel testing with #CostBenefitModel. hubs.ly/Q02ZBdkg0 Turun yliopisto - University of Turku University of Helsinki ASCPT Alexandria






Over 380K vancomycin treatment courses were used to evaluate the predictive performance of various vancomycin PK models across diverse age and BMI categories. Learn how to apply these findings to your patient. buff.ly/4hVye3J InsightRX Steph Hughes Michael Rybak



A new study concluded that following the implementation of a pharmacist-driven #AUCMonitoring program, patients were less likely to develop nephrotoxicity during outpatient #vancomycin therapy. hubs.ly/Q02_hD4k0 | #PrecisionMedicine #AntimicrobialTherapy Brigham and Women's Hospital



In this episode of the Oncology Unplugged series, 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏, Norton Healthcare Cancer Institute, hosted a conversation with Vivek Subbiah, MD, Sarah Cannon Docs. Learn more via OncLive.com: hubs.ly/Q02_NGRn0 | #PrecisionMedicine #PrecisionOncology MJH Life Sciences®



A new study examines the link between #vancomycin supratherapeutic dosing & #AKI using a novel correlation factor equation. Key finding: All AKIs occurred with AUC <600—pharmacists should assess other AKI causes. Author: Yazan Batarseh, HolyokeMedicalCenter: hubs.ly/Q030xh2T0




This recent study addresses the question, can we extract unrecognized #SADRs with known #PK mechanisms from biomedical literature using natural language processing tools & validate DDIs-SADR signals through multi-source EHR databases? hubs.ly/Q030F1Hp0 | ASCPT Alexandria


